PUF Agraflora Organics International

AgraFlora Provides Dial-In Information for Annual General Meeting and Business Update Presentation

AgraFlora Provides Dial-In Information for Annual General Meeting and Business Update Presentation

VANCOUVER, British Columbia, March 24, 2021 (GLOBE NEWSWIRE) -- (“AgraFlora” or the “Company”) (CSE: ) (Frankfurt: ) (OTCPK: is pleased to provide the following dial-in information for the Company’s upcoming Annual General Meeting (“AGM” or the “Meeting”) scheduled to be held at 10:00 AM Pacific Daylight Time on March 26, 2021. Shareholders and proxyholders may access the AGM via teleconference by dialing toll-free at 1-800-319-7310, then entering participation code “77783” followed by the pound (“#”) sign.   Following the close of the formal part of the Meeting, a business update presentation will be provided by AgraFlora’s new Chief Executive Officer, Ms. Elise Coppens. On the day of the Meeting, copy of the business update presentation will be made available for download on the Company’s website at .

In consideration of the COVID-19 pandemic, the Company asks that shareholders and proxyholders attend the AGM via teleconference and not attend the Meeting in person at the address provided on the Notice of Annual General Meeting of Shareholders. Prospective attendees should be advised that, between the date of this news release and the time of the AGM, AgraFlora may take additional precautionary measures in relation to the Meeting in response to new developments either directly or indirectly related to the evolving COVID-19 pandemic, which may not be able to be communicated until the time of the Meeting. As such, the Company encourages shareholders and proxyholders to vote prior to the Meeting.  

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a leading cannabis company building shareholder value through the development of revenue generating operating assets in the global cannabis industry. AgraFlora is focused primarily on the Canadian cannabis industry – the world’s most advanced and regulated legal cannabis market. Flagship Canadian assets include: Edibles & Infusions, a fully automated manufacturing facility in Winnipeg, MB for white-label and consumer-branded edibles production; Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC focused on reshaping the Canadian flower market with high-potency, low-cost cannabis; and AAA Heidelberg, a craft-focused cannabis producer in London, ON. In addition, AgraFlora’s wholly-owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active distribution operations in Germany and expects to commence active operations in the United Kingdom in 2021. For more information about AgraFlora, please visit and its profile page on SEDAR at .

ON BEHALF OF THE BOARD OF DIRECTORS

Nick Kuzyk, Investor Relations

E:

T: (800) 783-6056

For French inquiries:

Maricom Inc.        

Remy Scalabrini                                                

E:

T: (888) 585-MARI

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Forward-looking Information Cautionary Statement

Except for statements of historic fact this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan” “expect” “project” “intend” “believe” “anticipate” “estimate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including but not limited to delays or uncertainties with regulatory approvals including that of the CSE. There are uncertainties inherent in forward-looking information including factors beyond the Company’s control. There are no assurances that the business plans for AgraFlora Organics described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators which are available at



EN
24/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agraflora Organics International

 PRESS RELEASE

CSE Bulletin: Name Change - AgraFlora Organics International Inc. (AGR...

Toronto, Ontario--(Newsfile Corp. - le 26 juillet/July 2021) AgraFlora Organics International Inc. has announced a name change to Agra Ventures Ltd. Shares will begin trading under the new name and with a new CUSIP number on July 28, 2021. The symbol will remain the same. Disclosure documents are available at www.thecse.com Please note that all open orders will be cancelled at the end of business on July 27, 2021. Dealers are reminded to re-enter their orders. _________________________________ AgraFlora Organic...

 PRESS RELEASE

AgraFlora Organics International Inc. Changing Name to Agra Ventures L...

AgraFlora Organics International Inc. Changing Name to Agra Ventures Ltd. Propagation Services Canada Subsidiary Also Re-Branded As Boundary Bay Cannabis to Coincide with the First Cannabis Crop Harvest VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- (“AGRA” or the “Company”) (CSE: ) (Frankfurt: ) (OTCPK: is pleased to announce that effective July 28, 2021, it will change its name (the ‘Name Change”) to Agra Ventures Ltd. (“Agra Ventures”) to better reflect the evolved vision and strategic direction of the Company under current leadership. The Canadian Securities Exchan...

 PRESS RELEASE

AgraFlora Announces Debt Settlement

AgraFlora Announces Debt Settlement VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) announces that its Board of Directors has approved the settlement of amounts owing for services rendered (the "Debt Settlement") through the issuance of common shares (the “Shares”). Pursuant to the Debt Settlement, the Company issued an aggregate amount of 803,783 Shares at a deemed price of $0.05 per Share. All Shares issued will be subject to a minimum hold period of four mont...

 PRESS RELEASE

AgraFlora Appoints Fiona Fitzmaurice as its New Chief Financial Office...

AgraFlora Appoints Fiona Fitzmaurice as its New Chief Financial Officer Former CFO Amicably Departing the Company to Facilitate the Transition VANCOUVER, British Columbia, May 05, 2021 (GLOBE NEWSWIRE) -- (“AgraFlora” or the “Company”) (CSE: ) (Frankfurt: ) (OTCPK: is pleased to announce that Fiona Fitzmaurice has been appointed as AgraFlora’s new Chief Financial Officer (“CFO”) effective May 1, 2021, subject to the final acceptance of the Canadian Securities Exchange (the “CSE”). Ms. Fitzmaurice is a Chartered Professional Accountant with over 14 years of experience in accounting and...

 PRESS RELEASE

AgraFlora Announces Farmako Supply Agreement of Proprietary THC Testki...

AgraFlora Announces Farmako Supply Agreement of Proprietary THC Testkits to STADAPHARM Wholly-Owned German Subsidiary Developed THC Testkits In-House to Help Pharmacists Identify Medical Cannabis VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) -- (“AgraFlora” or the “Company”) (CSE: ) (Frankfurt: ) (OTCPK: is pleased to announce that its wholly-owned subsidiary, Farmako GmbH (“Farmako”) – a GDP certified pharmaceutical wholesaler with a focus on the cannabinoid therapy – has begun supplying STADAPHARM GmbH (“STADAPHARM”) with its proprietary THC Testkits (the “THC Testkit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch